Mabilat C, Courvalin P
Unité des Agents Antibactériens, Institut Pasteur, Paris, France.
Antimicrob Agents Chemother. 1990 Nov;34(11):2210-6. doi: 10.1128/AAC.34.11.2210.
Based on the DNA sequences of blaTEM-1 and blaTEM-2, which encode parental penicillinases TEM-1 and TEM-2, respectively, and blaTEM-3, blaTEM-4, blaTEM-5, blaTEM-6, and blaTEM-7, which encode extended-spectrum beta-lactamases, we designed heptadecanucleotides to discriminate point mutations in five loci. Determination of the hybridization profiles by colony hybridization with this selection of probes, termed "oligotyping," allowed characterization of the TEM variants present in 265 clinical isolates of the family Enterobacteriaceae that exhibit synergism between a penicillinase inhibitor and broad-spectrum cephaslosporins. Among the 222 strains harboring TEM enzymes, Klebsiella pneumoniae (48%) and Escherichia coli (21%) were predominant, and TEM-3 was the most common enzyme (60%). Penicillinases TEM-1 and TEM-2 were detected alone (15 and 1%, respectively), combined (1%), or associated with another TEM beta-lactamase (17 and 6%, respectively). Fourteen variants, including seven new enzymes, were detected. One, TEM-13, was a new penicillinase with the same isoelectric point and substrate range as TEM-2 but differed by a single amino acid substitution, whereas the others, TEM-14 to TEM-19, were extended-spectrum beta-lactamases that consisted of novel combinations of known amino acid substitutions. Different TEM variants were found to coexist within the same cells. A patient could harbor two or three different strains that encoded the same enzyme or two indistinguishable isolates that produced distinct TEM beta-lactamases.
基于分别编码亲本青霉素酶TEM-1和TEM-2的blaTEM-1和blaTEM-2的DNA序列,以及编码超广谱β-内酰胺酶的blaTEM-3、blaTEM-4、blaTEM-5、blaTEM-6和blaTEM-7,我们设计了十七聚核苷酸以区分五个位点的点突变。通过用这种称为“寡核苷酸分型”的探针组合进行菌落杂交来确定杂交图谱,从而能够对265株肠杆菌科临床分离株中存在的TEM变体进行表征,这些分离株在青霉素酶抑制剂和广谱头孢菌素之间表现出协同作用。在222株携带TEM酶的菌株中,肺炎克雷伯菌(48%)和大肠杆菌(21%)占主导地位,TEM-3是最常见的酶(60%)。单独检测到青霉素酶TEM-1和TEM-2(分别为15%和1%)、联合检测到(1%)或与另一种TEMβ-内酰胺酶相关联检测到(分别为17%和6%)。检测到14种变体,包括7种新酶。其中一种,TEM-13,是一种新的青霉素酶,其等电点和底物范围与TEM-2相同,但仅在一个氨基酸取代上有所不同,而其他的,TEM-14至TEM-19,是超广谱β-内酰胺酶,由已知氨基酸取代的新组合组成。发现不同的TEM变体共存于同一细胞内。一名患者可能携带两种或三种编码相同酶的不同菌株,或者两种产生不同TEMβ-内酰胺酶的难以区分的分离株。